$79.43
1.18% day before yesterday
Nasdaq, Jan 02, 10:00 pm CET

Mesa Laboratories, Inc. Stock price

$79.43
+3.37 4.43% 1M
-21.20 21.07% 6M
+0.93 1.18% YTD
-52.54 39.81% 1Y
-86.78 52.21% 3Y
-199.77 71.55% 5Y
-20.67 20.65% 10Y
+64.56 434.04% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
+0.93 1.18%

Key metrics

Basic
Market capitalization
$438.6m
Enterprise Value
$593.1m
Net debt
$154.4m
Cash
$20.4m
Shares outstanding
5.5m
Valuation (TTM | estimate)
P/E
negative | 40.4
P/S
1.8 | 1.7
EV/Sales
2.4 | 2.3
EV/FCF
15.9
P/B
2.5
Dividends
DPS
$0.64
Yield 1Y | 5Y
0.8% | 0.3%
Growth 1Y | 5Y
0.0% | 0.0%
Payout 1Y | 3Y
-177.8% | -4.1%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$245.3m | $252.9m
EBITDA
$31.9m | $58.9m
EBIT
$15.0m | $19.0m
Net Income
$-1.6m | $10.8m
Free Cash Flow
$37.3m
Growth (TTM | estimate)
Revenue
7.4% | 5.0%
EBITDA
6.7% | 72.9%
EBIT
22.5% | 8.4%
Net Income
99.4% | 649.8%
Free Cash Flow
4.3%
Margin (TTM | estimate)
Gross
62.2%
EBITDA
13.0% | 23.3%
EBIT
6.1%
Net
-0.6% | 4.3%
Free Cash Flow
15.2%
Financial Health
Equity Ratio
36.9%
Return on Equity
-1.2%
ROCE
3.9%
ROIC
-0.8%
Debt/Equity
1.0
More
EPS
$-0.3
FCF per Share
$6.8
Short interest
7.5%
Employees
736
Rev per Employee
$330.0k
Show more

Is Mesa Laboratories, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Mesa Laboratories, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Mesa Laboratories, Inc. forecast:

6x Buy
67%
3x Hold
33%

Analyst Opinions

9 Analysts have issued a Mesa Laboratories, Inc. forecast:

Buy
67%
Hold
33%

Financial data from Mesa Laboratories, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
245 245
7% 7%
100%
- Direct Costs 93 93
8% 8%
38%
152 152
7% 7%
62%
- Selling and Administrative Expenses 100 100
7% 7%
41%
- Research and Development Expense 20 20
7% 7%
8%
32 32
7% 7%
13%
- Depreciation and Amortization 17 17
4% 4%
7%
EBIT (Operating Income) EBIT 15 15
23% 23%
6%
Net Profit -1.57 -1.57
99% 99%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Mesa Laboratories, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Mesa Laboratories, Inc. Stock News

Neutral
GlobeNewsWire
16 days ago
LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens, President and CEO, and John Sakys, CFO will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, 2026. Management will participate...
Neutral
GlobeNewsWire
about 2 months ago
LAKEWOOD, Colo., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that Gary Owens, President and CEO, and John Sakys, CFO will be attending the following upcoming conferences:
Neutral
GlobeNewsWire
3 months ago
LAKEWOOD, Colo., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2026 following market close on Thursday, November 6, 2025.
More Mesa Laboratories, Inc. News

Company Profile

Mesa Laboratories, Inc. engages in the design, manufacture, and marketing of instruments and disposable products utilized in healthcare, pharmaceutical, food, and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection, Instruments, Cold Chain Monitoring, and Cold Chain Packaging. The Sterilization and Disinfection segment offers testing services, along with the manufacturing and marketing of biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. The Instrument segment manufactures and markets control instruments and disposable products. The Cold Chain Monitoring segment designs, develops, and markets systems which are used to monitor environmental parameters such as temperature, humidity, and differential pressure. The Cold Chain Packaging segment provides consulting services including compliance monitoring, packaging development, and validation or mapping of transport and storage containers, and thermal packaging products. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.

Head office United States
CEO Gary Owens
Employees 736
Founded 1982
Website mesalabs.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today